Captor Therapeutics SA (CTX) Stock Price & News

CTX:WSE

Captor Therapeutics SA

PLN 70.80

+1.00%

(+0.70) 1D

Sep 28, 5:00:00 PM GMT+2 · PLN

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Sep 15, 2026

Fiscal period

Q2 2026

EPS / Est. (PLN)

- / -

Revenue / Est. (PLN)

1.63M / 1.50M

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in PLN

Loading Previous Earnings...

All values in PLN	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	2.01M	-	44.00K	328.00K
Cost of goods sold	2.59M	-2.02M	-	-
Cost of revenue	2.59M	-2.02M	-	-
Research and development expenses	10.19M	14.74M	9.82M	10.56M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.35M	1.37M	2.53M	1.92M
Operating expense	10.16M	13.83M	10.40M	11.59M
Total operating expenses	12.76M	11.81M	10.40M	11.59M
Operating income	-10.74M	-11.81M	-10.36M	-11.26M
Other non operating income	-	1.00K	-8.00K	-
EBT including unusual items	-9.76M	-11.48M	-10.05M	-11.35M
EBT excluding unusual items	-9.76M	-11.48M	-10.12M	-11.35M
Income tax expense	-	-	-	27.00K
Effective tax rate	-	-	-	-0.24%
Other operating expenses	-4.38M	-2.27M	-1.94M	-893.00K
Net income	-9.76M	-11.48M	-10.05M	-11.38M
Net profit margin	-485.32%	-	-22,831.82%	-3,467.99%
Earnings per share	-	-	-	-
Interest and investment income	847.00K	391.00K	303.00K	39.00K
Interest expense	-36.00K	-61.00K	-75.00K	-67.00K
Net interest expenses	811.00K	330.00K	228.00K	-28.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-9.43M	-10.81M	-9.53M	-10.36M
Gain or loss from assets sale	682.00K	-682.00K	-	-

Finance